Hb S-β-thalassemia: molecular, hematological and clinical comparisons
Clinical and hematological features are presented for 261 patients with identified β-thalassemia (β-thal) mutations. Mutations causing Hb S [β6(A3)Glu→Val]-β0-thal were IVS-II-849 (A>G) in 44%, frameshift codon (FSC) 6 (-A) in 14%, Hb Monroe [β30(B12)Arg→Thr] in 14%, and IVS-II-1 (G>A) in 10%....
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
20 Jan. 2011
|
| In: |
Hemoglobin
Year: 2011, Volume: 35, Issue: 1, Pages: 1-12 |
| ISSN: | 1532-432X |
| DOI: | 10.3109/03630269.2010.546306 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3109/03630269.2010.546306
|
| Author Notes: | Graham R. Serjeant, Beryl E. Serjeant, Raphael A. Fraser, Ian R. Hambleton, Douglas R. Higgs, Andreas E. Kulozik, Alan Donaldson |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 182329667X | ||
| 003 | DE-627 | ||
| 005 | 20230710101607.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221123s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3109/03630269.2010.546306 |2 doi | |
| 035 | |a (DE-627)182329667X | ||
| 035 | |a (DE-599)KXP182329667X | ||
| 035 | |a (OCoLC)1389745752 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Serjeant, Graham R. |d 1938- |e VerfasserIn |0 (DE-588)1196052042 |0 (DE-627)167793963X |4 aut | |
| 245 | 1 | 0 | |a Hb S-β-thalassemia |b molecular, hematological and clinical comparisons |c Graham R. Serjeant, Beryl E. Serjeant, Raphael A. Fraser, Ian R. Hambleton, Douglas R. Higgs, Andreas E. Kulozik, Alan Donaldson |
| 246 | 3 | 3 | |a Hb S-beta-thalassemia |
| 264 | 1 | |c 20 Jan. 2011 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.11.2022 | ||
| 520 | |a Clinical and hematological features are presented for 261 patients with identified β-thalassemia (β-thal) mutations. Mutations causing Hb S [β6(A3)Glu→Val]-β0-thal were IVS-II-849 (A>G) in 44%, frameshift codon (FSC) 6 (-A) in 14%, Hb Monroe [β30(B12)Arg→Thr] in 14%, and IVS-II-1 (G>A) in 10%. Mutations causing Hb S-β+-thal with 14-25% Hb A (type III) were -29 (A>G) mutation in 60%, -88 (C>T) in 22% and the polyadenylation signal site (polyA) (T>C) mutation in 14%, and in Hb S-β+-thal with 1-7% Hb A (type I), all had the IVS-I-5 (G>C) mutation. Hematologically, only minor differences occurred between the four Hb S-β0-thal mutations, but among the three mutations causing Hb S-β+-thal type III, levels of Hb A2, Hb F, hemoglobin (Hb), MCV and MCH were highest in the -88 and lowest in the polyA mutations. Clinically, Hb S-β0-thal and Hb S-β+-thal type I were generally severe, and Hb S-β+-thal type III disease with the -88 mutation was milder than that caused by the polyA mutation. | ||
| 650 | 4 | |a Hb S-β+-thalassemia (β+-thal) | |
| 650 | 4 | |a Hb S-β0-thalassemia (β0-thal) | |
| 650 | 4 | |a Thalassemia mutations | |
| 650 | 4 | |a β+-Thalassemia (β+-thal) trait | |
| 650 | 4 | |a β0-Thalassemia (β0-thal) trait | |
| 700 | 1 | |a Serjeant, Beryl E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fraser, Raphael A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hambleton, Ian R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Higgs, Douglas R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kulozik, Andreas |d 1959- |e VerfasserIn |0 (DE-588)1025736567 |0 (DE-627)723892032 |0 (DE-576)167091638 |4 aut | |
| 700 | 1 | |a Donaldson, Alan |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Hemoglobin |d Abingdon : Taylor & Francis Group, 1976 |g 35(2011), 1 vom: Jan., Seite 1-12 |h Online-Ressource |w (DE-627)359787363 |w (DE-600)2098388-8 |w (DE-576)273886703 |x 1532-432X |7 nnas |a Hb S-β-thalassemia molecular, hematological and clinical comparisons |
| 773 | 1 | 8 | |g volume:35 |g year:2011 |g number:1 |g month:01 |g pages:1-12 |g extent:12 |a Hb S-β-thalassemia molecular, hematological and clinical comparisons |
| 856 | 4 | 0 | |u https://doi.org/10.3109/03630269.2010.546306 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20221123 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 1025736567 |a Kulozik, Andreas |m 1025736567:Kulozik, Andreas |d 910000 |d 910500 |e 910000PK1025736567 |e 910500PK1025736567 |k 0/910000/ |k 1/910000/910500/ |p 6 | ||
| 999 | |a KXP-PPN182329667X |e 4218753709 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"20 Jan. 2011"}],"id":{"doi":["10.3109/03630269.2010.546306"],"eki":["182329667X"]},"recId":"182329667X","name":{"displayForm":["Graham R. Serjeant, Beryl E. Serjeant, Raphael A. Fraser, Ian R. Hambleton, Douglas R. Higgs, Andreas E. Kulozik, Alan Donaldson"]},"title":[{"title_sort":"Hb S-β-thalassemia","title":"Hb S-β-thalassemia","subtitle":"molecular, hematological and clinical comparisons"}],"person":[{"display":"Serjeant, Graham R.","role":"aut","given":"Graham R.","family":"Serjeant"},{"display":"Serjeant, Beryl E.","family":"Serjeant","role":"aut","given":"Beryl E."},{"display":"Fraser, Raphael A.","family":"Fraser","given":"Raphael A.","role":"aut"},{"family":"Hambleton","given":"Ian R.","role":"aut","display":"Hambleton, Ian R."},{"family":"Higgs","given":"Douglas R.","role":"aut","display":"Higgs, Douglas R."},{"family":"Kulozik","given":"Andreas","role":"aut","display":"Kulozik, Andreas"},{"given":"Alan","role":"aut","family":"Donaldson","display":"Donaldson, Alan"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"12 S."}],"language":["eng"],"relHost":[{"language":["eng"],"pubHistory":["1.1976/77 -"],"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"Hemoglobin","subtitle":"international journal for hemoglobin research","title_sort":"Hemoglobin"}],"disp":"Hb S-β-thalassemia molecular, hematological and clinical comparisonsHemoglobin","recId":"359787363","part":{"extent":"12","text":"35(2011), 1 vom: Jan., Seite 1-12","volume":"35","pages":"1-12","year":"2011","issue":"1"},"origin":[{"publisherPlace":"Abingdon ; Philadelphia, PA","publisher":"Taylor & Francis Group ; Informa Healthcare","dateIssuedKey":"1976","dateIssuedDisp":"1976-"}],"id":{"eki":["359787363"],"zdb":["2098388-8"],"issn":["1532-432X"]}}],"titleAlt":[{"title":"Hb S-beta-thalassemia"}],"note":["Gesehen am 23.11.2022"]} | ||
| SRT | |a SERJEANTGRHBSTHALASS2020 | ||